342 related articles for article (PubMed ID: 23459190)
61. Neutrophil Heterogeneity in Cancer: From Biology to Therapies.
Lecot P; Sarabi M; Pereira Abrantes M; Mussard J; Koenderman L; Caux C; Bendriss-Vermare N; Michallet MC
Front Immunol; 2019; 10():2155. PubMed ID: 31616408
[TBL] [Abstract][Full Text] [Related]
62. Bone marrow myeloid cells in regulation of multiple myeloma progression.
Herlihy SE; Lin C; Nefedova Y
Cancer Immunol Immunother; 2017 Aug; 66(8):1007-1014. PubMed ID: 28378067
[TBL] [Abstract][Full Text] [Related]
63. Aptamer-mediated blockade of IL4Rα triggers apoptosis of MDSCs and limits tumor progression.
Roth F; De La Fuente AC; Vella JL; Zoso A; Inverardi L; Serafini P
Cancer Res; 2012 Mar; 72(6):1373-83. PubMed ID: 22282665
[TBL] [Abstract][Full Text] [Related]
64. Myeloid-derived suppressor cells in parasitic infections.
Van Ginderachter JA; Beschin A; De Baetselier P; Raes G
Eur J Immunol; 2010 Nov; 40(11):2976-85. PubMed ID: 21061431
[TBL] [Abstract][Full Text] [Related]
65. On the dual roles and polarized phenotypes of neutrophils in tumor development and progression.
Piccard H; Muschel RJ; Opdenakker G
Crit Rev Oncol Hematol; 2012 Jun; 82(3):296-309. PubMed ID: 21798756
[TBL] [Abstract][Full Text] [Related]
66. The Role of Myeloid-Derived Cells in the Progression of Liver Disease.
Weston CJ; Zimmermann HW; Adams DH
Front Immunol; 2019; 10():893. PubMed ID: 31068952
[TBL] [Abstract][Full Text] [Related]
67. Myeloid-derived suppressor cells--their role in haemato-oncological malignancies and other cancers and possible implications for therapy.
Tadmor T; Attias D; Polliack A
Br J Haematol; 2011 Jun; 153(5):557-67. PubMed ID: 21477210
[TBL] [Abstract][Full Text] [Related]
68. uPA and uPA-receptor are involved in cancer-associated myeloid-derived suppressor cell accumulation.
Ilkovitch D; Carrio R; Lopez DM
Anticancer Res; 2012 Oct; 32(10):4263-70. PubMed ID: 23060546
[TBL] [Abstract][Full Text] [Related]
69. Tuning the Tumor Myeloid Microenvironment to Fight Cancer.
Jahchan NS; Mujal AM; Pollack JL; Binnewies M; Sriram V; Reyno L; Krummel MF
Front Immunol; 2019; 10():1611. PubMed ID: 31402908
[TBL] [Abstract][Full Text] [Related]
70. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
Greifenberg V; Ribechini E; Rössner S; Lutz MB
Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
[TBL] [Abstract][Full Text] [Related]
71. Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients.
Filipazzi P; Huber V; Rivoltini L
Cancer Immunol Immunother; 2012 Feb; 61(2):255-263. PubMed ID: 22120756
[TBL] [Abstract][Full Text] [Related]
72. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
[TBL] [Abstract][Full Text] [Related]
73. Myeloid derived suppressor cells and their role in tolerance induction in cancer.
Fujimura T; Mahnke K; Enk AH
J Dermatol Sci; 2010 Jul; 59(1):1-6. PubMed ID: 20570112
[TBL] [Abstract][Full Text] [Related]
74. Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells.
Nefedova Y; Fishman M; Sherman S; Wang X; Beg AA; Gabrilovich DI
Cancer Res; 2007 Nov; 67(22):11021-8. PubMed ID: 18006848
[TBL] [Abstract][Full Text] [Related]
75. Inflammatory cell infiltration of tumors: Jekyll or Hyde.
Talmadge JE; Donkor M; Scholar E
Cancer Metastasis Rev; 2007 Dec; 26(3-4):373-400. PubMed ID: 17717638
[TBL] [Abstract][Full Text] [Related]
76. Transcriptional regulation of myeloid-derived suppressor cells.
Condamine T; Mastio J; Gabrilovich DI
J Leukoc Biol; 2015 Dec; 98(6):913-22. PubMed ID: 26337512
[TBL] [Abstract][Full Text] [Related]
77. Rational targeting of immunosuppressive neutrophils in cancer.
Zhao Y; Rahmy S; Liu Z; Zhang C; Lu X
Pharmacol Ther; 2020 Aug; 212():107556. PubMed ID: 32343986
[TBL] [Abstract][Full Text] [Related]
78. Neutrophils as active regulators of the immune system in the tumor microenvironment.
Shaul ME; Fridlender ZG
J Leukoc Biol; 2017 Aug; 102(2):343-349. PubMed ID: 28264904
[TBL] [Abstract][Full Text] [Related]
79. The dichotomy of neutrophil granulocytes in cancer.
Brandau S
Semin Cancer Biol; 2013 Jun; 23(3):139-40. PubMed ID: 23454237
[TBL] [Abstract][Full Text] [Related]
80. Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study.
Mandruzzato S; Brandau S; Britten CM; Bronte V; Damuzzo V; Gouttefangeas C; Maurer D; Ottensmeier C; van der Burg SH; Welters MJ; Walter S
Cancer Immunol Immunother; 2016 Feb; 65(2):161-9. PubMed ID: 26728481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
